Yahoo Finance Shire plc : Director/PDMR Shareholding
Director/PDMR Shareholding October 3, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities
1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | ||
a) | Name | Susan Kilsby | |
2. | Reason for the notification | ||
a) | Position / status | Chairman - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
Identification code | ISIN: US82481R1068 | ||
b) | Nature of the transaction | Acquisition of ADSs, being the part of Ms. Kilsby`s total fees that are paid in ADSs for the period of service from July 1 to September 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
See appendix below | |||
d) | Aggregated information | Weighted average price | Volume |
$152.5659 | 178 | ||
e) | Date of the transaction | September 29, 2017 | |
f) | Place of the transaction | XNAS / ARCX / MSPL | |
1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | ||
a) | Name | William Burns | |
2. | Reason for the notification | ||
a) | Position / status | Senior Independent Director - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc Ordinary Shares of 5 pence each ("Ordinary Shares") | |
Identification code | ISIN: JE00B2QKY057 | ||
b) | Nature of the transaction | Acquisition of Ordinary Shares, being the part of Mr. Burns` total fees that are paid in Ordinary Shares for the period of service from July 1 to September 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
See appendix below | |||
d) | Aggregated information | Weighted average price | Volume |
£37.8504 | 193 | ||
e) | Date of the transaction | September 29, 2017 | |
f) | Place of the transaction | XLON / BATE / CHIX / MSPL / TRQX | |
1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | ||
a) | Name | Dominic Blakemore | |
2. | Reason for the notification | ||
a) | Position / status | Non-Executive Director - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc Ordinary Shares of 5 pence each ("Ordinary Shares") | |
Identification code | ISIN: JE00B2QKY057 | ||
b) | Nature of the transaction | Acquisition of Ordinary Shares, being the part of Mr. Blakemore`s total fees that are paid in Ordinary Shares for the period of service from July 1 to September 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
See appendix below | |||
d) | Aggregated information | Weighted average price | Volume |
£37.8504 | 180 | ||
e) | Date of the transaction | September 29, 2017 | |
f) | Place of the transaction | XLON / BATE / CHIX / MSPL / TRQX | |
1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | ||
a) | Name | Olivier Bohuon | |
2. | Reason for the notification | ||
a) | Position / status | Non-Executive Director - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc Ordinary Shares of 5 pence each ("Ordinary Shares") | |
Identification code | ISIN: JE00B2QKY057 | ||
b) | Nature of the transaction | Acquisition of Ordinary Shares, being the part of Mr. Bohuon`s total fees that are paid in Ordinary Shares for the period of service from July 1 to September 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
See appendix below | |||
d) | Aggregated information | Weighted average price | Volume |
£37.8504 | 170 | ||
e) | Date of the transaction | September 29, 2017 | |
f) | Place of the transaction | XLON / BATE / CHIX / MSPL / TRQX | |
1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | ||
a) | Name | Ian Clark | |
2. | Reason for the notification | ||
a) | Position / status | Non-Executive Director - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
Identification code | ISIN: US82481R1068 | ||
b) | Nature of the transaction | Acquisition of ADSs, being the part of Mr. Clark`s total fees that are paid in ADSs for the period of service from July 1 to September 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
See appendix below | |||
d) | Aggregated information | Weighted average price | Volume |
$152.5659 | 49 | ||
e) | Date of the transaction | September 29, 2017 | |
f) | Place of the transaction | XNAS / ARCX / MSPL | |
1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | ||
a) | Name | Gail Fosler | |
2. | Reason for the notification | ||
a) | Position / status | Non-Executive Director - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
Identification code | ISIN: US82481R1068 | ||
b) | Nature of the transaction | Acquisition of ADSs, being the part of Ms. Fosler`s total fees that are paid in ADSs for the period of service from July 1 to September 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
See appendix below | |||
d) | Aggregated information | Weighted average price | Volume |
$152.5659 | 48 | ||
e) | Date of the transaction | September 29, 2017 | |
f) | Place of the transaction | XNAS / ARCX / MSPL | |
1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | ||
a) | Name | Steven Gillis | |
2. | Reason for the notification | ||
a) | Position / status | Non-Executive Director - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
Identification code | ISIN: US82481R1068 | ||
b) | Nature of the transaction | Acquisition of ADSs, being the part of Dr. Gillis` total fees that are paid in ADSs for the period of service from July 1 to September 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
See appendix below | |||
d) | Aggregated information | Weighted average price | Volume |
$152.5659 | 58 | ||
e) | Date of the transaction | September 29, 2017 | |
f) | Place of the transaction | XNAS / ARCX / MSPL | |
1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | ||
a) | Name | David Ginsburg | |
2. | Reason for the notification | ||
a) | Position / status | Non-Executive Director - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
Identification code | ISIN: US82481R1068 | ||
b) | Nature of the transaction | Acquisition of ADSs, being the part of Dr. Ginsburg`s total fees that are paid in ADSs for the period of service from July 1 to September 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
See appendix below | |||
d) | Aggregated information | Weighted average price | Volume |
$152.5659 | 54 | ||
e) | Date of the transaction | September 29, 2017 | |
f) | Place of the transaction | XNAS / ARCX / MSPL | |
1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | ||
a) | Name | Sara Mathew | |
2. | Reason for the notification | ||
a) | Position / status | Non-Executive Director - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
Identification code | ISIN: US82481R1068 | ||
b) | Nature of the transaction | Acquisition of ADSs, being the part of Ms. Mathew`s total fees that are paid in ADSs for the period of service from July 1 to September 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
See appendix below | |||
d) | Aggregated information | Weighted average price | Volume |
$152.5659 | 51 | ||
e) | Date of the transaction | September 29, 2017 | |
f) | Place of the transaction | XNAS / ARCX / MSPL | |
1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | ||
a) | Name | Anne Minto | |
2. | Reason for the notification | ||
a) | Position / status | Non-Executive Director - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc Ordinary Shares of 5 pence each ("Ordinary Shares") | |
Identification code | ISIN: JE00B2QKY057 | ||
b) | Nature of the transaction | Acquisition of Ordinary Shares, being the part of Ms. Minto`s total fees that are paid in Ordinary Shares for the period of service from July 1 to September 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
See appendix below | |||
d) | Aggregated information | Weighted average price | Volume |
£37.8504 | 190 | ||
e) | Date of the transaction | September 29, 2017 | |
f) | Place of the transaction | XLON / BATE / CHIX / MSPL / TRQX | |
1. | Details of the person discharging managerial responsibilities ("PDMR") / person closely associated with them ("PCA") | ||
a) | Name | Albert Stroucken | |
2. | Reason for the notification | ||
a) | Position / status | Non-Executive Director - PDMR | |
b) | Initial notification / amendment | Initial notification | |
3. | Details of the issuer, emission allowance participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Shire plc | |
b) | LEI | 54930005LQRLI2UXRQ59 | |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) | Description of the financial instrument, type of instrument | Shire plc American Depositary Shares ("ADSs") | |
Identification code | ISIN: US82481R1068 | ||
b) | Nature of the transaction | Acquisition of ADSs, being the part of Mr. Stroucken`s total fees that are paid in ADSs for the period of service from July 1 to September 30, 2017. | |
c) | Price(s) and volume(s) | Price(s) | Volume(s) |
See appendix below | |||
d) | Aggregated information | Weighted average price | Volume |
$152.5659 | 59 | ||
e) | Date of the transaction | September 29, 2017 | |
f) | Place of the transaction | XNAS / ARCX / MSPL | |
Appendix: individual / aggregated transaction details for PDMRs
Shire plc American Depositary Shares | ||
Place of the transaction | Price(s) | Volume(s) |
XNAS | $152.5900 | 100 |
ARCX | $152.5900 | 97 |
MSPL | $152.5500 | 300 |
Weighted average price | Aggregated volume | |
Total | $152.5659 | 497 |
Shire plc Ordinary Shares of 5 pence each | ||
Place of the transaction | Price(s) | Volume(s) |
XLON | £37.8500 | 242 |
XLON | £37.8500 | 91 |
XLON | £37.8500 | 91 |
BATE | £37.8500 | 2 |
BATE | £37.8500 | 75 |
CHIX | £37.8500 | 165 |
MSPL | £37.9150 | 4 |
TRQX | £37.8500 | 63 |
Place of the transaction | Weighted average price | Aggregated volume |
XLON | £37.8500 | 424 |
BATE | £37.8500 | 77 |
CHIX | £37.8500 | 165 |
MSPL | £37.9150 | 4 |
TRQX | £37.8500 | 63 |
Total | £37.8504 | 733 |
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
Investor Relations | ||
Ian Karp | +1 781 482 9018 | |
Robert Coates | +44 1256 894874 | |
Media | ||
Lisa Adler | lisa.adler@shire.com | +1 617 588 8607 |
Katie Joyce | kjoyce@shire.com | +1 781 482 2779 |
NOTES TO EDITORS
About Shire
Shire is the leading global biotechnology company focused on serving people with rare diseases. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.
Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Shire plc via GlobeNewswire
HUG#2139054
